InvestorsHub Logo
Followers 10
Posts 782
Boards Moderated 0
Alias Born 02/08/2007

Re: DewDiligence post# 540

Sunday, 01/13/2019 7:23:32 PM

Sunday, January 13, 2019 7:23:32 PM

Post# of 7112
<<Most likely, EOLS will settle on a price comparable to Dysport and Xeomin—i.e. a modest discount to Botox.>>


Why wouldn't a new player, entering an entrenched market, try to disrupt things by significantly undercutting price? Would you have had similar verbiage after Amphastar received approval for Enoxaparin?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News